IBM stock dipped on a minor earnings miss, but the weakness looks temporary. Click here to read more about the IBM stock.
Inventiva is positioned as a high-risk, clinical catalyst play targeting MASH with its oral pan-PPAR agonist, lanifibranor.
Spread the loveFor years, the conversation around home energy independence largely revolved around solar panels. And for good ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results